So why didn't they publish the data pertaining to the trial? As far as I'm concerned clinical significance is just as important as statistical significance with this and the only data made available was to do with regaining smell function.
Hopefully we'll see it in the quarterly
- Forums
- ASX - By Stock
- SPL
- Ann: Viraleze shows antiviral efficacy in COVID-19 patients
Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-44
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 109616 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 128702 | 0.098 |
1 | 6185 | 0.097 |
3 | 35417 | 0.096 |
4 | 602490 | 0.095 |
2 | 30000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 105000 | 2 |
0.110 | 114609 | 7 |
0.115 | 68531 | 5 |
0.120 | 89055 | 5 |
0.125 | 281784 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SPL (ASX) Chart |